Monitor-to-central-station bus
Proprietary monitor protocols typically run on the clinical VLAN with minimal authentication - integrity of waveform and alarm traffic must be explicit in the threat model and tested in the network pen test.
Cybersecurity for ICU/OR multiparameter monitors, capnography, anesthesia workstations, and central-station networks.
Multiparameter monitors, central stations, and anesthesia workstations form the densest networked footprint in any hospital. They consume HL7 and proprietary monitor protocols at line rate, surface real-time alarms, and span ICU, OR, ED, and step-down units on flat clinical VLANs. We build premarket and postmarket cybersecurity packages tuned to the monitor-to-central-station bus, HL7/EHR egress, and the vendor remote-service tooling that's become the most common entry point into these fleets.
Proprietary monitor protocols typically run on the clinical VLAN with minimal authentication - integrity of waveform and alarm traffic must be explicit in the threat model and tested in the network pen test.
Bedside-to-EHR gateways and alarm-forwarding services translate proprietary streams to HL7/FHIR with implicit trust - the threat model must treat both sides as untrusted and exercise the translation surface.
Jump hosts, support tunnels, and field-service laptops are the most common entry point into monitoring fleets - the postmarket plan must cover them as a continuous surface, not a one-time review.
Network-driven alarm silencing is a documented patient-safety hazard - any remote path that can suppress, mute, or re-route alarms must be authenticated, audited, and modeled explicitly.
Monitors and anesthesia workstations carry the densest real-time networked traffic in the hospital. The central-station bus, the bedside-to-EHR gateway, and the vendor remote-service path together carry every waveform, parameter, and alarm a clinician acts on.
Layers shown outermost (top) to innermost (bottom). Dashed rows are part of the surrounding system but out of scope for this view.
Patient-monitor and anesthesia incidents span Philips IntelliVue advisories, the GE Aestiva/Aespire anesthesia disclosure, URGENT/11 reach across monitoring fleets, and a recurring pattern of central-station and remote-service tooling compromise.
Historical incidents
Multiple CISA advisories (ICSMA-20-296-01, ICSMA-22-167-01) disclosed vulnerabilities in Philips IntelliVue patient-monitor and information-center families covering improper authentication, exposed services, and parameter-handling weaknesses on the clinical network.
CISA ICSMA-20-296-01CISA ICSMA-22-167-01
ICS-CERT advisory ICSMA-19-190-01 (CVE-2019-10966) disclosed that on certain serial-to-Ethernet deployments, attackers on the connected network could silence alarms and alter device parameters on GE Aestiva and Aespire anesthesia workstations - the canonical reviewer reference for alarm-state integrity.
CISA ICSMA-19-190-01CVE-2019-10966
ICS-CERT advisory ICSMA-17-264-01 disclosed authentication and encryption weaknesses in Capsule (Qualcomm Life) Datacaptor Terminal Server widely deployed to bridge monitors to EHRs - reviewers cite this pattern when assessing bedside-to-EHR gateway designs.
CISA ICSMA-17-264-01
Active threat scenarios
Proprietary monitor-to-central protocols that lack authentication and integrity allow waveform, alarm, or parameter traffic to be injected or replayed - a direct alarm-integrity hazard under IEC 60601-1-8.
Aestiva/Aespire-class root cause: any remote path that can silence, suppress, or re-route alarms must be authenticated and audited; unauthenticated paths are documented patient-safety hazards.
Datacaptor-class root cause: gateway services with weak authentication translate trusted-by-default monitor data into HL7/FHIR with downstream implicit trust - both sides need to be modeled as untrusted.
Remote-service tooling is the recurring entry point into monitoring fleets - jump-host architecture, account custody, session recording, and the responsibility boundary must be exercised end to end.
What FDA reviewers cite
Patient monitors and anesthesia workstations carry the densest real-time networked traffic in any hospital and drive alarm-based clinical decisions - waveform and alarm integrity are first-class patient-safety hazards, not data-protection concerns.
Proprietary monitor-to-central protocols predate modern auth assumptions - the threat model must enumerate waveform, alarm, and parameter integrity and the SPDF must show what authentication holds on which paths.
IEC 60601-1-8 treats alarm behavior as essential performance; any network path that can mute, suppress, or re-route alarms must be modeled and tested as a patient-safety hazard.
Jump hosts and field-service laptops are the most common entry point into monitoring fleets - they belong in the postmarket plan, not as a one-time premarket review.
Monitor fleets span ICU, OR, ED, and step-down units on shared infrastructure - postmarket plans must address fleet-wide patching, central-station upgrades, and cross-unit migration.
Standards & deliverables
Six deliverables FDA and notified bodies expect across MedTech, with the patient monitoring / anesthesia-specific wrinkle on each row. Use it as a scoping checklist before you brief vendors or your QA team.
| Deliverable | Status | Cadence | Standard / guidance | Patient Monitoring / Anesthesia note |
|---|---|---|---|---|
| SBOM + VEX Machine-readable SBOM (CycloneDX/SPDX) plus VEX feed for every CVE that touches a listed component. |
Required | Premarket + monthly refresh | FDA Cybersecurity Guidance §V · CISA SBOM minimum elements | SBOM must cover monitor firmware, central-station software, bedside-to-EHR gateways, and any vendor middleware - reviewers cross-check against IntelliVue and Aestiva references. |
| Postmarket monitoring Continuous CVE / advisory monitoring against the SBOM, with a documented triage and disclosure path. |
Required | Continuous (≤30-day triage) | FD&C Act §524B · FDA Postmarket Cybersecurity Guidance | Continuous monitoring must include the bedside-to-EHR gateway stack and any vendor middleware, both recurring CVE sources. |
| Penetration test scope Black/grey-box testing across device, wireless interfaces, mobile apps, cloud APIs, and service tooling. |
Required | Premarket + on material change | AAMI TIR57 · FDA Premarket Cyber Guidance §VI.A.5 | Pen test scope: monitor-to-central proprietary bus, HL7/FHIR egress, alarm-suppression paths, vendor remote-service jump hosts. |
| Threat model STRIDE-per-interface threat model with documented mitigations and residual-risk acceptance. |
Required | Premarket, refreshed each design change | AAMI TIR57 · FDA Premarket Cyber Guidance §V.A | Model the clinical VLAN as hostile; treat waveform, parameter, and alarm state as safety-critical writable state under IEC 60601-1-8. |
| Secure update mechanism Signed firmware/software updates with rollback protection, integrity verification, and staged rollout. |
Required | Designed premarket, exercised lifecycle-long | FDA Cyber Guidance §IV · IEC 81001-5-1 | Updates must address fleet-wide central-station upgrades and cross-unit migration, not just individual-device patching. |
| Coordinated Vulnerability Disclosure Public CVD policy, intake channel, and SLAs for triage, fix, and customer communication. |
Required | Continuous, lifecycle-long | ISO/IEC 29147 + 30111 · Section 524B(b)(2) | CVD policy must reach biomed engineers and hospital security teams alongside security researchers, with named jump-host architecture in the postmarket plan. |
Machine-readable SBOM (CycloneDX/SPDX) plus VEX feed for every CVE that touches a listed component.
Continuous CVE / advisory monitoring against the SBOM, with a documented triage and disclosure path.
Black/grey-box testing across device, wireless interfaces, mobile apps, cloud APIs, and service tooling.
STRIDE-per-interface threat model with documented mitigations and residual-risk acceptance.
Signed firmware/software updates with rollback protection, integrity verification, and staged rollout.
Public CVD policy, intake channel, and SLAs for triage, fix, and customer communication.
Monitors and central stations carry the densest real-time networked traffic in the hospital and they're directly tied to alarm-driven clinical decisions. A compromise that suppresses or alters waveforms or alarms is a patient-safety event, not just a data issue. Reviewers expect the threat model to enumerate waveform integrity, alarm integrity, and silence-state abuse as first-class hazards, with positive evidence of authentication and integrity on the monitor-to-central-station path.
We characterize the protocol on a staging fleet (never on a live clinical network), then exercise authentication, integrity, replay, and injection of waveform and alarm traffic. Network segmentation assumptions are made explicit in the SPDF and verified in the pen test. Findings cross-reference the IEC 60601-1-8 alarm hazards so safety and security teams act on the same evidence.
Yes. Bedside-to-EHR gateways and third-party alarm-forwarding services are scoped as their own components: HL7/FHIR translation surface, message authentication, downstream-system trust assumptions, and the alarm-forwarding integrity chain. IHE PCD profiles are referenced where applicable so the architecture is interoperability-aware as well as security-aware.
Remote-service tooling is the most common entry point into monitoring fleets. The postmarket plan documents jump-host architecture, account custody, session recording, and the boundary between vendor and hospital responsibility. The pen test includes the remote-service path end to end so reviewers can see it's been exercised rather than assumed safe.
Anesthesia workstations combine monitoring, ventilation, and gas-delivery on one platform, so the threat model spans IEC 60601-2-13 essential performance plus the OR-network and AIMS-integration paths. We scope them alongside ICU monitors when manufacturers ship both, with anesthesia-specific hazards (gas concentration, vaporizer control, agent identification) called out separately.
For a connected multiparameter monitor with central station and EHR gateway, end-to-end premarket cyber work runs 10-14 weeks. Threat modeling and SBOM front-load in weeks 1-4, pen testing across monitor, central station, gateway, and remote-service tooling runs in weeks 4-11, and the consolidated submission package and postmarket plan close in the final weeks - all under a written clearance guarantee.
Waveform and alarm-integrity threat models, central-station pen testing, and HL7/EHR egress assessment - tuned to IEC 60601-1-8 alarm hazards.
"Blue Goat Cyber's depth of expertise was impressive. We had no in-house cybersecurity experience, and their team guided us through every step of the FDA process. The penetration testing and SBOM testing were thorough and gave us complete confidence."
Cybersecurity for ICU/OR multiparameter monitors, capnography, anesthesia workstations, and central-station networks.